1 Gu D F, Kelly T N, Wu X, et al. Mortality attributable to smoking in China. N Engl J Med, 2009, 360: 150-159？？
[2]
2 McLellan A T, Lewis D C, O’Brien C P, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA, 2000, 284: 1689-1695？？
[3]
3 Mizoue T, Tokui N, Nishisaka K. Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Intern J Epidem, 2000, 29: 232-237？？
[4]
4 Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smokingccessation. Arch Intern Med, 2006, 166: 1571-1577？？
[5]
5 Ray R, Schnoll R A, Lerman C. Nicotine dependence: biology, behavior, and treatment. Annu Rev Med, 2009, 60: 247-260？？
[6]
6 Rigotti A N. Treatment on tobacco use and dependence. N Engl J Med, 2002, 346: 506-512？？
[7]
7 Moxham J. Nicotine addiction. BMJ, 2000, 7232: 391-392
[8]
8 Picciotto M R, Zoli M, Rimondini R. Acetyl-choline receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature, 1998, 6663: 173-177
[9]
9 Tapper A R, McKinney S L, Nashmi R. Nicotine activation of a4* receptors: sufficient for reward, tolerance, and sensitization. Science, 2004, 306: 1029-1032？？
[10]
10 Bencherif M, Fowler K, Lukas R J. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther, 1995, 275: 987-999
[11]
11 Peng X, Gerzanich V, Anand R. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol, 1994, 46: 523-530
[12]
12 Breese C R, Marks M J, Logel J. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther, 1997, 282: 7-13
[13]
13 Besson M, Granon S, Mameli-Engvall M. Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci USA, 2007, 104: 8155-8160？？
[14]
14 Nestler E J. Molecuhr mechanisms of drug addiction. Neu Ropharm, 2004, 47: 24-32
[15]
15 Eschenauer G, Sweet B V. Pharmacology and therapeutic uses of theanine. Am J Health-Syst Ph, 2006, 63: 26-30？？
17 Nguyen H N, Rasmussen B A, Perry D C. Subtypeselective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther, 2003, 307: 1090-1097？？
[18]
18 Huang E Y, Liu T C, Tao P L. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn-Schmiedebergs Arch Pharmacol, 2003, 368: 386-392？？
[19]
19 Laviolette S R, Nader K, Kooy D V. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res, 2002, 129: 17-29？？
[20]
20 Jiang H, Luan Z, Wang J, et al. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int, 2006, 49: 605-609？？
[21]
21 Shachar B D, Youdim M B. Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson''s disease may depend on iron±melanin interaction. J Neural Transm Suppl, 1990, 29: 251-255
[22]
22 Bezard E, Dovero S, Bioulac B, et al. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Neurosci Lett, 1997, 234: 43-45？？
[23]
23 Gross C E, Ravenscroft P, Dovero S, et al. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice. J Neurochem, 2003, 84: 1246-1251？？
[24]
24 Miller R G. Simultaneous Statistical Inference. New York: Springer, 1981. 230
[25]
25 Mansvelder H D, Keath J R, McGehee D S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron, 2002, 33: 905-919？？
[26]
26 Panagis G, Nisell M, Nomikos G G. Nicotine injections into the Ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus ac-Cumbens of the rat. Brain Res, 1996, 730: 133-142
[27]
27 Rahman S, Zhang J, Corrigall W A. Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: in vivo microdialysis. Neurosci Lett, 2003, 348: 61-64？？
[28]
28 Ferrafi R, Le Novere N, Picciotto M R. Acute and long—term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci, 2002, 15: 1810-1818？？
[29]
29 Corrigall W A, Coen K M, Adamson K L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res, 1994, 653: 278-284？？
[30]
30 Markou A, Paterson N E. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res, 2001, 3: 361-373？？
[31]
31 Lapchak P A, Araujo D M, Quirion R. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. J Neurochem, 1989, 52: 483-491？？
[32]
32 Lapin E P, Maker H S, Sershen H. Action of nicotine on accumbens dopamine and attenuation with repeated administration. Eur J Pharmacol, 1989, 160: 53-59？？
[33]
33 Marks M J, Burch J B, Collins A C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther, 1983, 226: 817-825
[34]
34 Sharp B M, Beyer H S, Levine A S. Attenuation of the plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats. J Pharmacol Exp Ther, 1987, 241: 438-442
[35]
35 Shram M J, Funk D, Li Z. Acute nicotine enhances c-FOS mRNA expression differen-Tially in reward-related substrates of adolescent and adult rat brain. Neuro Sci, 2007, 418: 286-291
[36]
36 Salminen O, Seppa T, Gaddnas H. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during Chronic nicotine infusion and its withdrawal. J Neuro Sci, 1999, 19: 8145-8151
[37]
37 Marks M J, Grady S R, Yang J M. Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. J Neurochem, 1994, 63: 2125-2135
[38]
38 Schwartz R D. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science, 1983, 220: 214-216？？
[39]
39 Benwell M E M, Balfour D J K. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity.Br J Pharmacol, 1992, 105: 849-856？？
[40]
40 Balbani A P S, Montovani J C. Methods for smoking cessation and treatment of nicotine dependence. Rev Bras Otorrinolaringol, 2005, 71: 820-826？？
[41]
41 Ray R, Schnoll R A, Lerman C. Nicotine dependence: biology, behavior, and treatment. Annu Rev Med, 2009, 60: 247-260？？
[42]
42 Rigotti A N. Treatment on tobacco use and dependence. N Engl J Med, 2002, 346: 506-512？？
[43]
43 Peng R L, Wang S L. Nicotine sublingual tablet for smoking cessation in 115 cases: a double-blind randomized placebo-controlled clinical trial. J Clin Rehabilit Tissue Engin Res, 2007, 11: 10443-10446
[44]
44 Liu Q, Tao Y, Zhao B L. ESR study on scavenging effect of nicotine on free radicals. Appl Mag Reson, 2003, 24: 105-112？？
[45]
45 Liu Q, Zhao B L. Nicotine attenuates β-amyloid peptide induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Brit J Pharmoco, 2004, l141: 746-754？？
[46]
46 Xie Y X, Bezard E, Zhao B L. Unraveling the receptor- independent neuroprotective mechanism in mitochondria. J Biol Chem, 2005, 396: 84-92
[47]
47 Zhang J, Liu Q, Liu N Q, et al. Nicotine reduces β-amyloidosis by regulating metal homeostasis. FASEB J, 2006, 20: 1212-1214？？
[48]
48 Liu Q, Zhang J, Qin C, et al. Dissecting the signalling pathway of nicotine-mediated neuroprotection in a mouse alzheimer disease model. FASEB J, 2007, 21: 61-73
50 Di X J, Yan Y, Zha J, et al. L-theanine protect the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway.Neuroscie, 2010, 168: 778-786？？
